Anaesthesia · Anaesthesia for Comorbidities (Cardiac, Respiratory, Renal, Hepatic, Endocrine)

A patient with end-stage renal disease on haemodialysis is receiving succinylcholine for rapid sequence intubation. The serum potassium measured 4 h after the last dialysis session is 5.1 mEq/L. What is the expected rise in serum K+ after succinylcholine administration?

  • A 0.1–0.2 mEq/L — same as in a normal patient
  • B 1.0–2.0 mEq/L due to upregulated extrajunctional receptors
  • C 4–5 mEq/L because haemodialysis potentiates depolarising blockade
  • D 0.5 mEq/L — the standard rise seen in all patients
Correct answer: D. 0.5 mEq/L — the standard rise seen in all patients

Explanation

In chronic renal failure without denervation injury or burns, succinylcholine causes the same 0.5 mEq/L rise in K+ as in a normal patient, making it safe when pre-dialysis K+ is ≤5.5 mEq/L. Dangerous hyperkalaemia (1–2+ mEq/L rise) occurs only when there is upregulation of extrajunctional ACh receptors due to denervation, immobilisation, burns, prolonged ICU stay, or crush injury — not simply from CKD alone.

Reference: Morgan & Mikhail's Clinical Anesthesiology, 6th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Anaesthesia for Comorbidities (Cardiac, Respiratory, Renal, Hepatic, Endocrine) MCQs

See all Anaesthesia for Comorbidities (Cardiac, Respiratory, Renal, Hepatic, Endocrine) MCQs →